Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS
- PMID: 19413503
- PMCID: PMC2856434
- DOI: 10.1089/apc.2008.0184
Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS
Abstract
Alcohol use is a barrier to medication adherence. Beyond the cognitive effects of intoxication, people living with HIV/AIDS who believe that alcohol should not be mixed with their medications may temporarily stop taking medications when drinking. To examine the effects of alcohol-treatment beliefs on HIV treatment adherence. People living with HIV/AIDS who were receiving treatment (n = 145) were recruited from community and clinical services during the period between January 2006 and May 2008 to complete measures of substance use and alcohol-antiretroviral (ARV) interactive toxicity beliefs (e.g., alcohol breaks down HIV medications so they will not work). Medication adherence was monitored using unannounced telephone-based pill counts. Forty percent of participants were currently using alcohol and nearly one in four drinkers reported stopping their medications when drinking. Beliefs that mixing alcohol and medications is toxic were common among drinkers and nondrinkers, with most beliefs endorsed more frequently by non-drinkers. Hierarchical regression analysis showed that stopping ARVs when drinking was associated with treatment nonadherence over and above quantity/frequency of alcohol use and problem drinking. Beliefs that alcohol and ARVs should not be mixed and that treatments should be interrupted when drinking are common among people living with HIV/AIDS. Clinicians should educate patients about the necessity of continuing to take ARV medications without interruption even if they are drinking alcohol.
Similar articles
-
Intentional non-adherence to medications among HIV positive alcohol drinkers: prospective study of interactive toxicity beliefs.J Gen Intern Med. 2013 Mar;28(3):399-405. doi: 10.1007/s11606-012-2231-1. Epub 2012 Oct 12. J Gen Intern Med. 2013. PMID: 23065532 Free PMC article.
-
Alcohol-antiretroviral therapy interactive toxicity beliefs and daily medication adherence and alcohol use among people living with HIV.AIDS Care. 2016 Aug;28(8):963-70. doi: 10.1080/09540121.2016.1154134. Epub 2016 Mar 10. AIDS Care. 2016. PMID: 26964014 Free PMC article.
-
Perceived sensitivity to medicines, alcohol interactive toxicity beliefs, and medication adherence among people living with HIV who drink alcohol.J Behav Med. 2019 Jun;42(3):392-400. doi: 10.1007/s10865-018-9987-7. Epub 2018 Oct 31. J Behav Med. 2019. PMID: 30382450
-
Alcohol-Antiretroviral Therapy Interactive Toxicity Beliefs and Intentional Medication Nonadherence: Review of Research with Implications for Interventions.AIDS Behav. 2021 Dec;25(Suppl 3):251-264. doi: 10.1007/s10461-021-03285-x. Epub 2021 May 5. AIDS Behav. 2021. PMID: 33950339 Review.
-
Alcohol Use and Antiretroviral Therapy Non-Adherence Among Adults Living with HIV/AIDS in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.AIDS Behav. 2020 Jun;24(6):1727-1742. doi: 10.1007/s10461-019-02716-0. AIDS Behav. 2020. PMID: 31673913 Free PMC article.
Cited by
-
Dysregulation of skeletal muscle protein metabolism by alcohol.Am J Physiol Endocrinol Metab. 2015 May 1;308(9):E699-712. doi: 10.1152/ajpendo.00006.2015. Epub 2015 Mar 10. Am J Physiol Endocrinol Metab. 2015. PMID: 25759394 Free PMC article. Review.
-
Patient and provider comfort discussing substance use.Fam Med. 2013 Feb;45(2):109-17. Fam Med. 2013. PMID: 23378078 Free PMC article.
-
The association between substance use and sub-optimal HIV treatment engagement among HIV-infected female sex workers in Lilongwe, Malawi.AIDS Care. 2017 Feb;29(2):197-203. doi: 10.1080/09540121.2016.1211244. Epub 2016 Jul 21. AIDS Care. 2017. PMID: 27442009 Free PMC article.
-
Alcohol use and antiretroviral adherence: review and meta-analysis.J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):180-202. doi: 10.1097/QAI.0b013e3181b18b6e. J Acquir Immune Defic Syndr. 2009. PMID: 19668086 Free PMC article. Review.
-
Development and validation of the East Africa Alcohol Expectancy Scale (AFEXS).J Stud Alcohol Drugs. 2015 Mar;76(2):336-43. doi: 10.15288/jsad.2015.76.336. J Stud Alcohol Drugs. 2015. PMID: 25785809 Free PMC article.
References
-
- Bangsberg DR. Kroetz DL. Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007;4:65–72. - PubMed
-
- Chesney M. Adherence to HAART Regimens. AIDS Patient Care STDs. 2003;17:169–177. - PubMed
-
- Berg CJ. Michelson SE. Safren SA. Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors. Infect Dis Clin North Am. 2007;21:181–200. - PubMed
-
- Braithwaite RS. McGinnis KA. Conigliaro J, et al. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcoholism Clin Exp Res. 2005;29:190–197. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical